News

Dune Acquisition Corporation II Announces Pricing of $125 Million Initial Public Offering
Dune Acquisition Corporation II (the “Company”) announced today the pricing of its initial public offering of 12,500,000 units at a price of $10.00 per unit. The units will be listed on The Nasdaq ...
The Business Times2h
OpenAI negotiates with Microsoft for new funding and future IPO, FT reports
Bengaluru] OpenAI and Microsoft are rewriting terms of their multibillion-dollar partnership in a negotiation designed to ...
OpenAI and Microsoft engage in tense negotiations over the future of their partnership
Once the best of friends, OpenAI and its most important financial backer Microsoft Corp. are now involved in tough ...
SFGate2d
Initial public offerings scheduled to debut next week
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. eToro - Bnei Brak, Israel, ...
Investment word of the day: Follow-on public offering — what is FPO and how is it different from IPO?
A follow-on public offer (FPO) allows listed companies to raise capital by issuing additional shares. Due to available ...
Houston Chronicle3d
Initial public offerings scheduled to debut next week
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings. eToro - Bnei Brak ...
OpenAI negotiating with Microsoft for new billion-dollar deal to clear path for future IPO: Report
OpenAI and Microsoft are in the midst of renegotiating their multibillion-dollar partnership, seeking to redefine the terms ...
Xpeng Is Said to Consider Flying Car IPO in Hong Kong or US
Xpeng Inc. is considering an initial public offering for its flying car unit, Xpeng Aeroht, according to people familiar with ...
The Manila Times3d
Apimeds Pharmaceuticals US, Inc. Announces Pricing of Initial Public Offering
Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) ('Apimeds” or the 'Company”), a clinical stage biopharmaceutical company that is in the process of developing Apitox, an intradermally ...